Cargando…
The role of m6A methylation in therapy resistance in cancer
Cancer therapy resistance is the main cause of cancer treatment failure. The mechanism of therapy resistance is a hot topic in epigenetics. As one of the most common RNA modifications, N6-methyladenosine (m6A) is involved in various processes of RNA metabolism, such as stability, splicing, transcrip...
Autores principales: | Zhuang, Hengzhao, Yu, Bo, Tao, Dan, Xu, Xiaoyan, Xu, Yijun, Wang, Jian, Jiao, Yang, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233906/ https://www.ncbi.nlm.nih.gov/pubmed/37264402 http://dx.doi.org/10.1186/s12943-023-01782-2 |
Ejemplares similares
-
Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma
por: Wang, Lili, et al.
Publicado: (2023) -
The role of mRNA m(6)A methylation in the nervous system
por: Li, Jiashuo, et al.
Publicado: (2019) -
Exploration of the Role of m(6) A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer
por: Wei, Qinglv, et al.
Publicado: (2021) -
The role of RNA m6A methylation in lipid metabolism
por: Wang, Yuting, et al.
Publicado: (2022) -
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
por: Chen, Zhaolin, et al.
Publicado: (2022)